Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1977 Apr 9;116(7):757–759.

Difference in the distribution of e antigen among different ethnic groups in a population of blood donors.

G Richer, D Phaneuf, F Boisvert, R Guévin, A Viallet
PMCID: PMC1879432  PMID: 849558

Abstract

Sensitive techniques were used to detect e antigen and the corresponding antibody (anti-e) among 368 voluntary blood donors positive for hepatitis B surface antigen in the Montreal area and 310 people living in close contact with them. Neither e nor anti-e was found in the absence of markers of hepatitis B virus (HBV). Among the blood donors e antigen was detected in 23 and anti-e in 313, and 32 were negative for both markers. Of the 368 blood donors 330 were of French origin and 38 from other ethnic groups. The 23 e-positive subjects were unequally distributed among the ethnic groups: only 14 (4.2%) were recruited among the French group while 9 (23.7%) were recruited among other ethnic groups (P less than 0.001). This differences among ethnic groups might be related to the vertical or horizontal mode of dissemination of HBV infection.

Full text

PDF
757

Images in this article

758FIG. 1
on p.758

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg B. S., Sutnick A. I., London W. T., Millman I. Australia antigen and hepatitis: a comprehensive review. CRC Crit Rev Clin Lab Sci. 1971 Sep;2(3):473–528. doi: 10.3109/10408367109151315. [DOI] [PubMed] [Google Scholar]
  2. El Sheikh N., Woolf I. L., Galbraith R. M., Eddleston A. L., Dymock I. W., Williams R. e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen. Br Med J. 1975 Nov 1;4(5991):252–253. doi: 10.1136/bmj.4.5991.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eleftheriou N., Thomas H. C., Heathcote J., Sherlock S. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet. 1975 Dec 13;2(7946):1171–1173. doi: 10.1016/s0140-6736(75)92657-4. [DOI] [PubMed] [Google Scholar]
  4. Lehmann-Grube F. Persistent infection of the mouse with the virus of lymphocytic choriomeningitis. J Clin Pathol Suppl (R Coll Pathol) 1972;6:8–21. [PMC free article] [PubMed] [Google Scholar]
  5. Magnius L. O., Espmark A. A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(2):335–337. doi: 10.1111/j.1699-0463.1972.tb00167.x. [DOI] [PubMed] [Google Scholar]
  6. Magnius L. O., Lindholm A., Lundin P., Iwarson S. A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. JAMA. 1975 Jan 27;231(4):356–359. doi: 10.1001/jama.231.4.356. [DOI] [PubMed] [Google Scholar]
  7. Maynard J. E., Barrett D. H., Murphy B. L., Bradley D. W., Berquist K. R., Bender T. R. Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity. J Infect Dis. 1976 Mar;133(3):339–342. doi: 10.1093/infdis/133.3.339. [DOI] [PubMed] [Google Scholar]
  8. Moore B. P., Meade D. Counter-immunoelectrophoresis for detection of hepatitis B antigen and antibody: a technique for large-scale use. Can J Public Health. 1972 Sep-Oct;63(5):453–459. [PubMed] [Google Scholar]
  9. Nielsen J. O., Dietrichson O., Juhl E. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. Lancet. 1974 Oct 19;2(7886):913–915. doi: 10.1016/s0140-6736(74)91127-1. [DOI] [PubMed] [Google Scholar]
  10. Okada K., Kamiyama I., Inomata M., Imai M., Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976 Apr 1;294(14):746–749. doi: 10.1056/NEJM197604012941402. [DOI] [PubMed] [Google Scholar]
  11. Richer G., Houle G., Viallet A., Turgeon F., Guévin R. Letter: Antibodies against coat HBAg. Lancet. 1974 Mar 2;1(7853):356–356. doi: 10.1016/s0140-6736(74)93107-9. [DOI] [PubMed] [Google Scholar]
  12. Schweitzer I. L., Edwards V. M., Brezina M. Letter: e Antigen in HBs Ag-carrier mothers. N Engl J Med. 1975 Oct 30;293(18):940–940. doi: 10.1056/NEJM197510302931823. [DOI] [PubMed] [Google Scholar]
  13. Skinhoj P., Cohn J., Bradburne A. F. Transmission of hepatitis type B from healthy HBsAg-positive mothers. Br Med J. 1976 Jan 3;1(6000):10–11. doi: 10.1136/bmj.1.6000.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16;170(3955):332–333. doi: 10.1126/science.170.3955.332. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES